Tryp Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial for the Treatment of…
Net revenues for the quarter ended September 30, 2023 reached a new Company record of $49.4 million, representing an increase of $13.6 million, or 38%, over net revenues reported for the comparable quarter ended September 30, 2022. This…